Study register · detail
Unclear
12 citations
SampleNarrative Review
Blindingn.a.
DesignNarrative Review
Key finding
Observational studies and surveys suggest perceived benefits, but prospective studies and RCTs are rare and the evidence remains sparse.
Summary
Narrative review on cannabis in rheumatic diseases; explicitly discusses fibromyalgia data; review of existing studies (incl. nabilone RCT in fibromyalgia) with moderate pain reduction; emphasizes safety concerns and evidence gaps.
SummaryNarrative review on medical cannabis for rheumatic pain. Notes an increase in observational studies and surveys with positive patient reports, but a lack of prospective RCTs. No pooled effect estimates or structured PICO data extractable.
Quality profile
Sample size
—
Blinding
—
Effect size
—
Citations / year
★★★★★
Authors
Share
Abstract
Purpose Of Review: Changing attitudes about Cannabis have led to an increase in use of medicinal Cannabis, especially for painful chronic conditions. Patients ask rheumatologists for guidance on this topic. This review provides up-to-date information on the safety and efficacy of medicinal cannabis for rheumatic disease pain.
Recent Findings: The number of publications related to rheumatic disease and cannabis has increased, but recent literature skews heavily toward reviews vs primary research. Data supporting a role for cannabinoids in rheumatic disease continue to grow. Observational and survey studies show increased use of medicinal cannabis, both by people with rheumatic disease and the general population, and suggest that patients find these treatments beneficial. Prospective studies, however, including randomized controlled clinical trials, are rare and sorely needed. As medicinal cannabis use for rheumatic diseases rises, despite lack of evidence, we review the sparse data available and provide tips for conversations about medicinal cannabis for rheumatologists. Media, LLC, part of Springer Nature.
The impediment to action advances action.